GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sedana Medical AB (OSTO:SEDANA) » Definitions » Gross Profit

Sedana Medical AB (OSTO:SEDANA) Gross Profit : kr116.3 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sedana Medical AB Gross Profit?

Sedana Medical AB's gross profit for the three months ended in Mar. 2024 was kr34.8 Mil. Sedana Medical AB's gross profit for the trailing twelve months (TTM) ended in Mar. 2024 was kr116.3 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Sedana Medical AB's gross profit for the three months ended in Mar. 2024 was kr34.8 Mil. Sedana Medical AB's Revenue for the three months ended in Mar. 2024 was kr48.8 Mil. Therefore, Sedana Medical AB's Gross Margin % for the quarter that ended in Mar. 2024 was 71.22%.

Sedana Medical AB had a gross margin of 71.22% for the quarter that ended in Mar. 2024 => Durable competitive advantage

During the past 9 years, the highest Gross Margin % of Sedana Medical AB was 76.56%. The lowest was 62.71%. And the median was 70.06%.


Sedana Medical AB Gross Profit Historical Data

The historical data trend for Sedana Medical AB's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sedana Medical AB Gross Profit Chart

Sedana Medical AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Profit
Get a 7-Day Free Trial Premium Member Only 46.77 88.90 106.71 86.07 108.98

Sedana Medical AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.49 26.59 23.94 30.96 34.77

Competitive Comparison of Sedana Medical AB's Gross Profit

For the Medical Devices subindustry, Sedana Medical AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sedana Medical AB's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Gross Profit distribution charts can be found below:

* The bar in red indicates where Sedana Medical AB's Gross Profit falls into.



Sedana Medical AB Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Sedana Medical AB's Gross Profit for the fiscal year that ended in Dec. 2023 is calculated as

Gross Profit (A: Dec. 2023 )=Revenue - Cost of Goods Sold
=153.867 - 44.886
=109.0

Sedana Medical AB's Gross Profit for the quarter that ended in Mar. 2024 is calculated as

Gross Profit (Q: Mar. 2024 )=Revenue - Cost of Goods Sold
=48.821 - 14.052
=34.8

Gross Profit for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr116.3 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Sedana Medical AB's Gross Margin % for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=34.8 / 48.821
=71.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Sedana Medical AB  (OSTO:SEDANA) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Sedana Medical AB had a gross margin of 71.22% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Sedana Medical AB Gross Profit Related Terms

Thank you for viewing the detailed overview of Sedana Medical AB's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Sedana Medical AB (OSTO:SEDANA) Business Description

Traded in Other Exchanges
Address
Vendevagen 89, Danderyd, SWE, SE-182 32
Sedana Medical AB is a Sweden-based medical technology company. It's Anaesthetic Conserving Device (AnaConDa) is an anaesthetic delivery system developed for the administration of volatile anaesthetics such as isoflurane or sevoflurane to invasively ventilated patients. AnaConDa is a small device that is inserted in the breathing circuit between the ET-Tube and the Y-piece. The product range of the group is AnaConDa, AnaConDa-S, AnaConDa syringe, FlurAbsorb-S, FlurAbsorb accessory kit, Nafion line, and others. The company operates in Sweden, Germany, Spain, Ireland, and France, out of which Germany accounts for the majority of the revenue.

Sedana Medical AB (OSTO:SEDANA) Headlines

No Headlines